Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Zelenka, Jaroslav ^a   Dvořák, Aleš ^b,c   Alán, Lukáš ^b   Zadinová, Marie ^b   Haluzík, Martin ^c,d   Vítek, Libor ^c  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL CULTURE; DISEASES; GLUCOSE; MEDICAL PROBLEMS; MITOCHONDRIA; RATS;

ANTHROPOMETRIC PARAMETERS; CARDIO-VASCULAR DISEASE; CELLULAR SENESCENCE; HUMAN EMBRYONIC KIDNEY CELLS; HYPERBILIRUBINEMIA; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL FUNCTION; PRO-INFLAMMATORY CYTOKINES;

PATHOLOGY;

BILIRUBIN; GLUTATHIONE; HYDROGEN PEROXIDE; INTERLEUKIN 18; INTERLEUKIN 1BETA; PROTEIN P16; PROTEIN P21; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR;

AGING; ANIMAL EXPERIMENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL CULTURE; CELL RESPIRATION; CONTROLLED STUDY; FIBROBLAST; GLUCOSE TOLERANCE; GUNN RAT; HUMAN; HYPERBILIRUBINEMIA; INFLAMMATION; INTRAPERITONEAL FAT; KIDNEY CELL; LIVER MITOCHONDRION; METABOLIC DISORDER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SENESCENCE; ANIMAL; BLOOD; COMPLICATION; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY;

AGING; ANIMALS; BILIRUBIN; CELLS, CULTURED; FIBROBLASTS; HYPERBILIRUBINEMIA; INFLAMMATION; INTRACELLULAR SPACE; METABOLIC DISEASES; MITOCHONDRIA; RATS, GUNN; REACTIVE OXYGEN SPECIES;

EID: 84986247533     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6190609     Document Type: Article

References (44)

1. L. Vek and J. D. Ostrow, "Bilirubin chemistry and metabolism; harmful and protective aspects, " Current Pharmaceutical Design, vol. 15, no. 25, pp. 2869-2883, 2009.
2. R. Stocker, Y. Yamamoto, A. F. McDonagh, A. N. Glazer, and B. N. Ames, "Bilirubin is an antioxidant of possible physiological importance, " Science, vol. 235, no. 4792, pp. 1043-1046, 1987.
3. R. Stocker, "Antioxidant activities of bile pigments, " Antioxidants & Redox Signaling, vol. 6, no. 5, pp. 841-849, 2004.
4. S. D. Zucker, W. Goessling, E. J. Bootle, and C. Sterritt, "Localization of bilirubin in phospholipid bilayers by parallax analysis of fluorescence quenching, " Journal of Lipid Research, vol. 42, no. 9, pp. 1377-1388, 2001.
5. H. Kaur, M. N. Hughes, C. J. Green, P. Naughton, R. Foresti, and R. Motterlini, "Interaction of bilirubin and biliverdin with reactive nitrogen species, " FEBS Letters, vol. 543, no. 1-3, pp. 113-119, 2003.
6. J. Zelenka, L. Muchova, M. Zelenkova et al., "Intracellular accumulation of bilirubin as a defense mechanism against increased oxidative stress, " Biochimie, vol. 94, no. 8, pp. 1821-1827, 2012.
7. T. Jansen, M. Hortmann, M. Oelze et al., "Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin, " Journal of Molecular and Cellular Cardiology, vol. 49, no. 2, pp. 186-195, 2010.
8. M. Ristow, "Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits, " Nature Medicine, vol. 20, no. 7, pp. 709-711, 2014.
9. K.-H. Wagner, M. Wallner, C. Mlzer et al., "Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases, " Clinical Science, vol. 129, no. 1, pp. 1-25, 2015.
10. W. W. Wang, D. L. H. Smith, andS. D. Zucker, "Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats, " Hepatology, vol. 40, no. 2, pp. 424-433, 2004.
11. S. Lanone, S. Bloc, R. Foresti et al., "Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats, " The FASEB Journal, vol. 19, no. 13, pp. 1890-1892, 2005.
12. R. Ollinger, P. Kogler, J. Troppmair et al., "Bilirubin inhibits tumor cell growth via activation of ERK, " Cell Cycle, vol. 6, no. 24, pp. 3078-3085, 2007.
13. R. Ollinger, M. Bilban, A. Erat et al., "A natural inhibitor of vascular smooth muscle cell proliferation, " Circulation, vol. 112, no. 7, pp. 1030-1039, 2005.
14. A. C. Bulmer, K. Ried, J. T. Blanchfield, andK.-H. Wagner, "The anti-mutagenic properties of bile pigments, " Mutation Research, vol. 658, no. 1-2, pp. 28-41, 2008.
15. A. Pflueger, A. J. Croatt, T. E. Peterson et al., "The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II, " American Journal of Physiology-Renal Physiology, vol. 288, no. 3, pp. F552-F558, 2005.
16. D. E. Stec, M. V. Storm, B. E. Pruett, and M. U. Gousset, "Antihypertensive actions of moderate hyperbilirubinemia: role of superoxide inhibition, " American Journal of Hypertension, vol. 26, no. 7, pp. 918-923, 2013.
17. M. Wallner, R. Marculescu, D. Doberer et al., "Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome, " Clinical Science, vol. 125, no. 5, pp. 257-264, 2013.
18. A. C. Bulmer, H. J. Verkade, and K.-H. Wagner, "Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection, " Progress in Lipid Research, vol. 52, no. 2, pp. 193-205, 2013.
19. U. S. National Institute of Aging and World Health Organization, Global Health and Aging, World Health Organization, Geneva, Switzerland, 2011.
20. G. Barja, "Updating the mitochondrial free radical theory of aging: an integrated view, key aspects, and confounding concepts, " Antioxidants & Redox Signaling, vol. 19, no. 12, pp. 1420-1445, 2013.
21. Y.-H. Youm, R. W. Grant, L. R. McCabe et al., "Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging, " Cell Metabolism, vol. 18, no. 4, pp. 519-532, 2013.
22. F. S. Facchini, N. Hua, F. Abbasi, and G. M. Reaven, "Insulin resistance as a predictor of age-related diseases, " Journal of Clinical Endocrinology andMetabolism, vol. 86, no. 8, pp. 3574-3578, 2001.
23. M. Collado, M. A. Blasco, and M. Serrano, "Cellular senescence in cancer and aging, " Cell, vol. 130, no. 2, pp. 223-233, 2007.
24. M. Lagouge and N.-G. Larsson, "The role of mitochondrial DNAmutations and free radicals in disease and ageing, " Journal of Internal Medicine, vol. 273, no. 6, pp. 529-543, 2013.
25. R. Konkov, K. Vankov, J. Vanov et al., "Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds, " Annals of Hepatology, vol. 13, no. 2, pp. 273-283, 2014.
26. M. Jaburek, J. Jezek, J. Zelenka, and P. Jezek, "Antioxidant activity by a synergyof redox-sensitivemitochondrial phospholipase A2 and uncoupling protein-2 in lung and spleen, " International Journal of Biochemistry and Cell Biology, vol. 45, no. 4, pp. 816-825, 2013.
27. A. F. McDonagh and F. Assisi, "The ready isomerization of bilirubin IX-in aqueous solution, " Biochemical Journal, vol. 129, no. 3, pp. 797-800, 1972.
28. V. V. Belousov, A. F. Fradkov, K. A. Lukyanov et al., "Genetically encoded fluorescent indicator for intracellular hydrogen peroxide, " Nature Methods, vol. 3, no. 4, pp. 281-286, 2006.
29. F. Debacq-Chainiaux, J. D. Erusalimsky, J. Campisi, and O. Toussaint, "Protocols to detect senescence-associated betagalactosidase (SA-gal) activity, a biomarker of senescent cells in culture and in vivo, " Nature Protocols, vol. 4, no. 12, pp. 1798-1806, 2009.
30. M. Qaisiya, C. D. Coda Zabetta, C. Bellarosa, and C. Tiribelli, "Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway, " Cellular Signalling, vol. 26, no. 3, pp. 512-520, 2014.
31. W. Guo, L. Jiang, S. Bhasin, S. M. Khan, and R. H. Swerdlow, "DNA extraction procedures meaningfully influence qPCRbased mtDNA copy number determination, " Mitochondrion, vol. 9, no. 4, pp. 261-265, 2009.
32. L. Aln, T. Spacek, J. Zelenka et al., "Assessment of mitochondrial DNA as an indicator of islet quality: an example in Goto Kakizaki rats, " Transplantation Proceedings, vol. 43, no. 9, pp. 3281-3284, 2011.
33. J. Zelenka, A. Dvork, and L. Aln, "L-lactate protects skin fibroblasts against aging-associated mitochondrial dysfunction via mitohormesis, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 351698, 14 pages, 2015.
34. C. M. P. Rodrigues, S. Sol, and D. Brites, "Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons, " Hepatology, vol. 35, no. 5, pp. 1186-1195, 2002.
35. P. Keshavan, S. J. Schwemberger, D. L. H. Smith, G. F. Babcock, and S. D. Zucker, "Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization, " International Journal of Cancer, vol. 112, no. 3, pp. 433-445, 2004.
36. S. Krller-Schn, S. Steven, S. Kossmann et al., "Molecular mechanisms of the crosstalk between mitochondria and nadph oxidase through reactive oxygen species-studies in white blood cells and in animal models, " Antioxidants & Redox Signaling, vol. 20, no. 2, pp. 247-266, 2014.
37. S. Gazzin, J. Zelenka, L. Zdrahalova et al., "Bilirubin accumulation and Cyp mRNA expression in selected brain regions of jaundiced Gunn rat pups, " Pediatric Research, vol. 71, no. 6, pp. 653-660, 2012.
38. J. Zelenka, M. Lenek, L. Muchov et al., "Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 867, no. 1, pp. 37-42, 2008.
39. C. Finelli, L. Sommella, S. Gioia, N. La Sala, and G. Tarantino, "Should visceral fat be reduced to increase longevity" Ageing Research Reviews, vol. 12, no. 4, pp. 996-1004, 2013.
40. R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, "A role for mitochondria in NLRP3 inflammasome activation, " Nature, vol. 469, no. 7329, pp. 221-225, 2011.
41. J. Campisi, "Aging, cellular senescence, and cancer, " Annual Review of Physiology, vol. 75, pp. 685-705, 2013.
42. M. C. Velarde, J. M. Flynn, N. U. Day, S. Melov, and J. Campisi, "Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin, " Aging, vol. 4, no. 1, pp. 3-12, 2012.
43. D. Harman, "The biologic clock: the mitochondria" Journal of the American Geriatrics Society, vol. 20, no. 4, pp. 145-147, 1972.
44. A. R. Mullen, Z. Hu, X. Shi et al., "Oxidation of alphaketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects, " Cell Reports, vol. 7, no. 5, pp. 1679-1690, 2014.